CD40LG and tuberculosis: On the days 21, 28 and 35 after the first immunization, the levels of anti-PCV2 antibodies in TB-Cap, TB-Cap-CD154 and TB-Cap-GM-CSF groups were significantly higher than that in the commercial vaccine group and PBS group (p < 0.0001).